Autopsy report · NCT02764411

Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations

“Poor enrollment, lack of feasibility”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 2 years 4 months before it stopped.
• 6 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

The Hospital for Sick Children

Sponsor type

University, hospital or other

Conditions

Capillary Malformations

Interventions

Brimonidine 0.33% gel

Participants

6

Sites

1

Countries

Canada

Trials that died the same way

• Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)
  “feasibility and low enrollment” (88% match in meaning)
• Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients
  “Lack of substantial enrollment” (85% match in meaning)
• Laser Treatment for Fresh Surgical Scars and Mature Scars
  “Poor enrollment” (85% match in meaning)
• Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study
  “Inadequate enrollment” (82% match in meaning)
• Use of Prokinetics in Early Enteral Feeding in Preterm Infants
  “very poor enrollment” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.